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Pithecolobine isolated from alkaloid extract of Albizia saman
showed antimicrobial activity against seven human pathogenic
bacteria and two yeasts with minimum inhibitory concentrations
(MIC) values of 1.9–125 μg mL−1. In addition, it also exhibited
antioxidant activity with IC50 value at 250μg mL−1. Pithecolobine
may be useful as a natural bioactive molecule for developing potent
antimicrobial and antioxidant agents.
KEYWORDS bioactives, DPPH radical scavenging assay, mini-
mum inhibitory concentrations, preparative TLC
INTRODUCTION
The diseases caused by pathogenic microbes pose major problems despite
the progress achieved in human health care (7, 16). The continued existence
of multidrug-resistant (MDR) pathogenic microbes to currently available
drugs has further complicated the treatment of diseases (9, 11). The free
radicals generated as by-products in living organisms during metabolic pro-
cess under oxidative stress conditions play a role in the onset of nearly
150 patho-physiological disorders such as arthritis, diabetes mellitus, inflam-
matory conditions, cancer, heart, genotoxicity diseases, and early aging (15).
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Currently a number of synthetic drugs have been used to prevent diseases
and disorders, but many of these synthetic agents are nonspecific and cause
serious side effects such as nephrotoxicity, hepatotoxicity, and neurotoxic-
ity, and fail to alleviate the diseases or disorders completely (8, 16, 22). The
increasing failures of synthetic chemotherapeutics and serious side effects
caused by synthetic drugs have collectively necessitated the need to look
for alternative strategies (11, 20). In the past two decades, there has been
increasing interest in searching for new and broad-spectrum drugs from nat-
ural products as alternatives to synthetic chemicals (14, 21). Alkaloids are
important bioactive substances and have been reported for their various
bioactivities (1, 6).
Albizia saman (Leguminosae) is rich in alkaloids and globally dis-
tributed throughout the tropical regions. The leaves are used in folk remedy
for stomach cancer, common cold, diarrhoea, headache, intestinal ailments,
sore throat, stomach ache, and wounds (18). Some biological activities of
this plant have been reported in aqueous and solvent extracts (3–5, 10, 17,
19, 24), and phytochemical analysis of this species revealed pithecolobine as
the main alkaloid (26, 27). Some biological activities have been reported for
pithecolobine (2). The present study was done to analyze the antimicrobial
and antioxidant activities of pithecolobine.
MATERIALS AND METHODS
Chemicals and Culture Media
Mueller-Hinton agar/broth (MHA/MHB), malt extract-glucose-yeast extract-
peptone-agar/broth (MGYPA/MGYPB), dimethyl sulfoxide (DMSO), β-
carotene, linoleic acid, neomycin (NM), and fluconazole (FZ) were pur-
chased from Hi-Media, Mumbai, India. All solvents, reagents, ascorbic acid,
and iodo-nitro-tetrazolium (INT) were purchased from SRL, Mumbai, India.
Microtiter-plates (96-well) were purchased from Axiva, New Delhi, India.
2,2-Diphenyl-1-picrylhydrazyl (DPPH) were obtained from Sigma, Steinheim,
Germany. Silica gel 60 F254-coated preparative thin-layer chromatography
(TLC) plates were obtained from Merck, Darmstadt, Germany.
Collection of Plant Sample and Identification
Fresh leaves of A. saman were collected from southern parts of Karnataka
(India) during 2010–2012, authenticated by JCB National Herbarium and
voucher specimen (BUB/MB-BT/DCM/JU10/33) deposited in JCB National
Herbarium, Indian Institute of Science, Bangalore, India.
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Isolation of Bioactive Compounds from Alkaloid Extracts
The leaves were shade-dried, powdered, and used for alkaloid extraction
(13). Briefly, 50 g of shade-dried powder was repeatedly extracted with
200 mL of 10% acetic acid in ethanol. The crude alkaloid was precipitated by
drop-wise addition of concentrated NH4OH. The precipitated alkaloid was
collected after centrifugation and subjected to isolation of bioactive com-
pound. The bioactive compound was extracted was as described earlier
(23). Briefly, the alkaloid extract was first subjected to silica gel col-
umn chromatography and eluted with gradient solvent systems of CHCl3
(100%), CH3OH (100%), and CH3OH:NH4OH (1:0.1 and 1:0.5). Twentieth
fraction, which showed highest activities, was subjected to preparative TLC
for further purification using the solvent system CH3OH:NH4OH (1:0.43).
The second band (Rf 0.43) showing broad-spectrum activity was collected
from TLC. The purity of compound was confirmed using solvent system
and subjected to spectral analysis (NMR, ESI-MS, and FT-IR) for structural
elucidation.
Antimicrobial Activity
MICROBIAL STRAINS
The pathogenic Escherichia coli (NCIM 2065), Klebsiella pneumoniae
(NCIM 2957), Proteus vulgaris (NCIM 2027), Pseudomonas aeruginosa
(NCIM 5031), Salmonella typhi (NCIM 2051), Staphylococcus aureus (NCIM
2079), Streptococcus faecalis (NCIM 5025), Candida albicans (NCIM 3471),
and Cryptococcus neoformans (NCIM 3541) were obtained from the
National Chemical Laboratory, Pune, India. All the tested bacteria and
fungi were maintained on MHA and MGYPA, respectively. The bac-
terial (24 h old) and fungal (48 h old) cultures were used as test
organisms.
DISC DIFFUSION METHOD
Briefly, sterile filter paper discs (6 mm in diameter) were individually impreg-
nated with 20 μL of twofold diluted pithecolobine dissolved in DMSO
(0.95–1000 μg/disc), then placed onto the pre-inoculated MHA/MGYP plates
(inoculum size: 100 μL of microbial suspension containing 108 cfu mL−1
of bacteria or 106 cfu mL−1 of fungi) and incubated at 37 ◦C for bacte-
ria and 30 ◦C for fungi. DMSO served as negative control, and twofold
diluted neomycin (for bacteria) and fluconazole (for fungi) served as pos-
itive controls. The zones of inhibition (ZOI) diameters (in mm) were
measured (8).
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DETERMINATION OF THE MICS AND MBCS/MFCS
The broth microdilution method was used to determine the minimum
inhibitory concentrations (MICs) and minimum bactericidal concentrations
(MBCs)/minimum fungicidal concentrations (MFCs) of pithecolobine follow-
ing the standard procedures with some modifications (7, 12). Briefly, 200
μL of twofold serially diluted pithecolobine in MHB or MGYPB (0.95–1000
μg mL−1) was added to the wells of a sterile 96-well microtiter plate and
inoculated with 15 μL of a microbial suspension containing 108 cfu mL−1 of
bacteria or 106 cfu mL−1 of fungi, respectively, and incubated at 37 ◦C for
bacteria (24 h) and 30 ◦C for fungi (48 h). DMSO served as a negative control,
and neomycin and fluconazole were used as positive controls. After incuba-
tion, the MIC values of the compounds were detected (12) by the addition of
50 μL of INT (2 mg mL−1). The MBC/MFC values were determined (7). 50 μL
of cultured broth (without INT) was radially streaked onto the MHA/MGYPA
media and further incubated as described above. The complete absence of
growth on the agar surface at the lowest concentration was defined as the
MBC/MFC.
Antioxidant Activity
The antioxidant activity of the pithecolobine was determined by DPPH rad-
ical scavenging and β-carotene/linoleic acid assays (8). In DPPH assay,
twofold dilutions of pithecolobine were made using methanol (ranging from
31–1000 μg mL−1). One mL of each dilution was mixed with 3 mL of freshly
prepared methanol solution of DPPH (40 μg mL−1) and incubated for 30 min
in the dark at room temperature. The same concentration of ascorbic acid
was used as positive control and a methanol solution of DPPH served as neg-
ative control. The absorbance of the solutions was recorded using a UV-Vis
spectrophotometer at 517 nm, and percent inhibition was calculated as:
I% = {(Acontrol − Asample)/Acontrol} × 100
where, Acontrol is the absorbance of the control reaction, and Asample is the
absorbance of the test samples.
In the β-carotene/linoleic acid assay, 500 μL of pithecolobine (2000
μg in 1000 μL methanol) was added to 2500 μL of β-carotene-linoleic acid
emulsion mixture separately, mixed thoroughly, and incubated at 50 ◦C for
2 h in water bath. Methanol was used as negative control and ascorbic acid
was used as positive control. The absorbance was measured at 470 nm using
UV-Vis spectrophotometer. The antioxidant activity (Inhibition percentage)
was calculated using following formula:
I% = (Aafter incubation/Abefore incubation) × 100
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where, Aafter incubation is the absorbance of β-carotene after 2 h, and
Abefore incubation is the absorbance of β-carotene at the beginning.
Statistical Analysis
Values were expressed as mean ± SE. Analysis of variance (ANOVA) was
performed and the means separated by Tukey’s multiple comparison tests
(P < 0.05) using SPSS 20 (IBM, USA).
RESULTS
Identification of Bioactive Compounds
The IR spectrum of active compounds showed characteristic absorption
peaks at (KBr) cm−1: 1646.47, 3353.94, and 2944.94 for strong C=O stretch,
N-H stretch, and alkane C-H stretch, respectively. In the positive mode
(M+H)+ ESI-MS, the active compound showed molecular ion peak (m/z)
at 383.53 corresponding to the molecular formula C22H46N4O (MW. 382.63).
The 1H NMR analysis of active compound showed characteristic peaks at
δ 0.996–1.01 (t, CH3, J = 8.0 Hz), 1.321–1.402 (m, 4CH2, J = 16.8 Hz),
1.605–1.741 (m, 6CH2, J = 12.0 Hz), 2.071–2.103 (t, 3CH2, J = 13.2 Hz),
2.158–2.196 (t, 3CH2, J = 15.2 Hz), 2.691 (s, CH), 2.707–2.750 (q, 4CH2, J
= 11.6 Hz), 3.229 (s, CH2), 8.6 (s, N-H), and the 13C NMR analysis showed
characteristic peaks at δ 14.92, 15.15, 21.97, 24.11, 24.21, 25.70, 26.91, 27.71,
28.55, 28.66, 29.34, 30.39, 31.05, 33.55, 35.47, 35.80, 38.54, 46.58, 48.86,
49.07, 50.14, 56.29, and 175.00. Further, based on cited literature data (27),
the isolated compound was identified as pithecolobine.
Antimicrobial Activity
The antimicrobial activity of pithecolobine was evaluated against human
pathogenic microorganisms including seven bacteria and two yeasts by mea-
suring the presence or absence of ZOI, MIC, and MBC/MFC values (Table 1).
The bioactive compound pithecolobine showed concentration-dependent
bactericidal activity against Gram-positive and Gram-negative bacteria, and
fungicidal activity against C. albicans and C. neoformans. The negative con-
trol DMSO did not inhibit any of the microorganisms tested. The maximum
ZOI, MIC, and MBC values were observed in the range of 7.6–24.8 mm,
1.9–125 μg mL−1, and 7.8–250 μg mL−1, respectively. Among the bacteria
tested, the Gram-positive S. faecalis was the most susceptible species, fol-
lowed by S. aureus, whereas the Gram-negative P. vulgaris was the most
resistant. Similarly, the human pathogenic yeasts viz., C. albicans and C.
neoformans were also inhibited strongly with ZOI, MIC and MFC ranging
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TABLE 1 Antimicrobial activity of pithecolobine against selected human pathogenic bacteria
and yeasts
Pithecolobine Neomycin/Fluconazole†
Organisms ZOIa MICb MBCc ZOIa MICb MBCc
Escherichia coli 15.3 ± 0.3 15.6 62.5 16.8 ± 0.2 3.9 7.8
Klebsiella pneumoniae 15.5 ± 0.3 15.6 31.2 17.1 ± 0.2 1.9 3.9
Proteus vulgaris 7.6 ± 0.2 125 250 20.3 ± 0.3 1.9 3.9
Pseudomonas aeruginosa 13.5 ± 0.3 31.2 62.5 16.6 ± 0.2 1.9 7.8
Salmonella typhi 15.8 ± 0.4 15.6 62.5 19.5 ± 0.3 1.9 3.9
Staphylococcus aureus 19.3 ± 0.3 3.9 15.6 19.5 ± 0.4 0.95 3.9
Streptococcus faecalis 24.8 ± 0.2 1.9 7.8 27.5 ± 0.3 0.95 1.9
Candida albicans 22.3 ± 0.3 7.8 31.2 33.3 ± 0.4∗ 31.2 >1000
Cryptococcus neoformans 20.1 ± 0.2 15.6 31.2 35.7 ± 0.3∗ 15.6 500
aZOIs at 0.25mg/disc (mm); bMICs (μg mL−1), cMBCs/MFCs (μg mL−1).
†Neomycin was used as positive control for bacteria and fluconazole for fungi.
∗Fungistatic zone.
from 20.1-22.3mm, 7.8-15.6 μg mL−1 and 31.2 μg mL−1, respectively. The
antibacterial and antifungal activities of the synthetic antibacterial (neomycin)
and antifungal (fluconazole) agents were also determined and compared
with the MIC and MBC/MFC values of pithecolobine. Increasing order of
inhibitory activity against bacteria was pithecolobine < neomycin and fungi
was fluconazole < pithecolobine.
Antioxidant Activity
In the DPPH radical scavenging assay, the IC50 value for the pithecolobine
was 250 μg mL−1 compared to 30 μg mL−1 for ascorbic acid. Using the
β-carotene/linoleic acid assay, the percent inhibition of β-carotene/linoleic
bleaching for the pithecolobine was at 70.4% compared to 93% for ascorbic
acid.
DISCUSSION
The increasing documentation of possible adverse effects of some synthetic
antimicrobial and antioxidant agents on human health, as well as the contin-
ued existence of multidrug-resistant (MDR) human pathogenic bacteria and
fungi to currently available antibiotics, lead to the necessity of finding new
biomolecules from natural sources for drug discovery and development (9,
11, 14). The identification of bioactive compounds from plants is one of the
promising and eco-friendly alternative strategies for the discovery of new
drugs (20). Alkaloids are important bioactive substances, and are reported to
D
ow
nl
oa
de
d 
by
 [B
an
ga
lor
e U
niv
ers
ity
] a
t 0
0:0
4 2
8 M
arc
h 2
01
6 
444 S. Thippeswamy et al.
have antimicrobial and antioxidant properties (1). A. saman, which is glob-
ally distributed throughout the tropical regions, is rich in alkaloids. While
leaves of A. saman are used as folk remedy for diseases, antimicrobial
activity reports exist of crude aqueous and solvent extracts of A. saman
against some human and plant pathogenic bacteria and fungi (2, 5, 17–
19, 24). Methanol extracts of Samanea saman demonstrated cytotoxic and
antioxidant activities in other studies (4, 5).
A wide range biological activities of A. saman and pithecolobine have
been reported previously (23, 26, 27). Pithecolobine isolated from S. saman
demonstrated antimicrobial activity against B. subtilis and plant pathogenic
molds (2). Another report showed antifungal antimycotoxigenic activities of
pithecolobine against storage molds (23).
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